查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826981

2025年放射肿瘤学全球市场报告

Radiotherapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，放射治疗市场规模强劲成长，从2024年的73.8亿美元增加至2025年的78.9亿美元，复合年增长率为7.0%。预测期内的增长归因于全球癌症发病率的上升、对非侵入性癌症治疗的需求不断增长、医疗基础设施的不断扩展、个性化医疗的普及以及需要癌症治疗的患者数量的不断增长。

预计未来几年放射治疗市场将强劲成长，到2029年将达到102.7亿美元，年复合成长率（CAGR）为6.8%。预测期内成长的驱动因素包括：对先进医疗技术的投资不断增加、对微创治疗方案的关注度不断提高、对家庭医疗保健解决方案的需求不断增长、对品质保证计划的关注度不断提高，以及针对癌症治疗的全球健康倡议日益增多。预测期内的主要趋势包括：影像导航放射治疗的进步、粒子治疗的进步、新型近距离放射治疗技术的研发、电脑刀技术的进步以及人工智慧在治疗计划中的整合。

放射疗法使用高剂量的放射线治疗方法破坏癌细胞并缩小肿瘤。它通常作为独立疗法使用，或与手术和化疗联合使用，以治疗多种类型的癌症。

放射治疗的主要类型包括体外放射治疗、内照射放射治疗和全身放射治疗。体外放射治疗使用外部设备的高能量辐射来瞄准并摧毁癌细胞。这种治疗方法治疗方法多种癌症，包括摄护腺癌、乳癌、肺癌、头颈癌、大肠癌、妇科癌、子宫颈癌和阴茎癌。它的最终用户包括医院和诊断实验室、癌症治疗和研究中心、学术机构以及门诊手术中心。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗机构正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，其中许多产品的国内替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原材料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供放射肿瘤学市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的放射肿瘤学细分市场、市场趋势和商业机会，以及在放射肿瘤学行业取得成功所需的数据。这份放射肿瘤学市场研究报告提供了您所需的一切信息，并详细分析了该行业的现状和未来趋势。

未来五年6.8%的成长率预测较先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将增加美国的发展，从而推迟晚期癌症治疗并增加放射肿瘤学支出。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响也将更加广泛。

癌症发生率的上升预计将推动放射治疗市场的扩张。癌症是一种以异常细胞不受控制地生长为特征的疾病，这些细胞会侵袭并转移到身体的其他部位，影响各种组织和器官，并引起各种症状。癌症发生率的上升与人口老化、生活方式的改变（包括不良饮食和缺乏运动）、大量吸烟和饮酒、环境污染以及能够早期发现的诊断工具的进步等因素有关。放射治疗在癌症治疗中发挥关键作用，它可以精准靶向并摧毁癌细胞，缩小肿瘤并改善患者预后。例如，2024年8月，英国一家支持癌症患者的慈善机构麦克米伦癌症援助组织报告称，英国有超过300万人患有癌症，并预测到2025年这一数字将增至350万，到2030年将增至400万，到2040年将增至530万。因此，癌症发生率的上升正在刺激放射治疗市场的成长。

放射治疗市场的主要企业正在优先开发创新技术，例如影像导航放射治疗(IGRT)，以提高治疗精度、改善患者预后并最大限度地减少对周围健康组织的损害。 IGRT 利用先进的成像工具确保放射治疗期间的精确肿瘤靶向，从而可以即时追踪和调整肿瘤位置以提高准确性。例如，2022 年 5 月，瑞典医疗技术公司 Elekta AB 推出了下一代放射线手术系统 Elekta Esprit，可增强立体定位放射线手术的功能。该系统将多种创新技术整合到一个平台中，为治疗团队提供卓越的可视化和远端存取。它支援灵活的工作流程选项，包括单次、分次、自适应和分阶段通讯协定，从而优化了临床环境中的易用性和效率。它旨在治疗最具挑战性的疾病，同时以低于 0.3 毫米的精度保护周围的健康组织。

2024年2月，美国製药公司百时美施贵宝收购了RayzeBio，具体金额未揭露。此次收购增强了该公司的肿瘤学产品线，使其拥有先进的放射性药物疗法，其中包括RYZ101，该药物靶向治疗胃肠道间质瘤-神经内分泌肿瘤（GEP-NETs）和早期小细胞肺癌（ES-SCLC）中的SSTR2基因。凭藉正在进行的临床试验和先进的生产设施，这项策略性倡议使百时美施贵宝能够加速创新，拓展治疗方案，并推动肿瘤学领域的成长。 RayzeBio是一家总部位于美国的公司，专注于开发用于治疗癌症的创新放射性药物。

放射治疗市场包括提供近距离放射治疗、安宁疗护、质子治疗和术中放射治疗等服务的营业单位所获得的收益。市场价值包括服务提供者销售的或包含在其服务产品中的任何相关商品的价值。放射治疗市场包括患者定位系统、表面导引放射治疗 (SGRT)、CT 和 MRI 模拟系统以及直线加速器的销售。此市场价值为“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球放射肿瘤学：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球放射肿瘤学市场：成长率分析
  • 全球放射肿瘤学市场表现：规模与成长，2019-2024
  • 全球放射肿瘤学市场预测：2024-2029年及2034年规模与成长
  • 全球放射肿瘤学：总目标市场（TAM）

第六章 市场细分

  • 全球放射肿瘤学市场（依治疗类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 体外放射治疗
  • 内部放射治疗
  • 全身放射线治疗
  • 全球放射肿瘤学市场：按应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 摄护腺癌
  • 乳癌
  • 肺癌
  • 头颈癌
  • 大肠直肠癌
  • 妇科癌症
  • 子宫颈癌
  • 阴茎癌
  • 其他用途
  • 全球放射肿瘤学市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊断实验室
  • 癌症治疗与研究中心
  • 学术研究机构
  • 门诊手术中心
  • 其他最终用户
  • 全球放射治疗市场：依体外放射治疗类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 强度调控放射治疗（IMRT）
  • 立体定位放射治疗（SBRT）
  • 3D适形放射治疗（3D-CRT）
  • 质子治疗
  • 影像导航放射治疗（IGRT）
  • 容积调强弧形治疗 (VMAT)
  • 全球放射肿瘤学市场：按内部放射治疗细分（按类型）、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 近距离放射治疗（高剂量率）
  • 近距离放射治疗（低剂量率）
  • 术中放射治疗（IORT）
  • 永久种子植入
  • 全球放射肿瘤学市场：依全身放射线治疗类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 放射性同位素治疗
  • 标靶放射性核素治疗
  • 放射免疫治疗
  • 胜肽受体放射性核种治疗（PRRT）

第七章 区域和国家分析

  • 全球放射肿瘤学市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球放射肿瘤学市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 放射肿瘤学市场：竞争格局
  • 放射肿瘤学市场：公司简介
    • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Elekta AB
  • Accuray Incorporated
  • Ion Beam Applications SA
  • Canon Medical Systems Corporation
  • RefleXion Medical Inc.
  • Mevion Medical Systems Inc.
  • Nordion Inc.
  • Theragenics Corporation
  • RaySearch Laboratories AB
  • MIM Software Inc.
  • Vision RT Ltd.
  • Sun Nuclear Corporation
  • Provision Healthcare LLC
  • Panacea Medical Technologies Pvt. Ltd.
  • Optivus Proton Therapy Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年放射肿瘤学市场：提供新机会的国家
  • 2029年放射肿瘤学市场：细分领域带来新机会
  • 2029年放射肿瘤学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r34133u

Radiotherapy is a medical treatment that utilizes high doses of radiation to destroy cancer cells and shrink tumors. It is commonly used to treat various types of cancer, either as a standalone therapy or in combination with surgery and chemotherapy.

The primary types of radiotherapy include external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy delivers high-energy radiation from an external machine to target and destroy cancer cells. This treatment is applied to various cancers, including prostate, breast, lung, head and neck, colorectal, gynecological, cervical, and penile cancers, among others. It is used by multiple end users, such as hospitals and diagnostic labs, cancer treatment and research centers, academic institutions, and ambulatory surgery centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The radiotherapy market research report is one of a series of new reports from The Business Research Company that provides radiotherapy market statistics, including the radiotherapy industry's global market size, regional shares, competitors with a radiotherapy market share, detailed radiotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy industry. This radiotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiotherapy market size has grown strongly in recent years. It will grow from $7.38 billion in 2024 to $7.89 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to an increase in the incidence of cancer cases globally, growth in demand for non-invasive cancer treatments, expansion of healthcare infrastructure, rise in adoption of personalized medicine, and rise in patient population requiring cancer treatment.

The radiotherapy market size is expected to see strong growth in the next few years. It will grow to $10.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing investment in advanced healthcare technologies, increasing focus on minimally invasive treatment options, rising demand for home-based healthcare solutions, increasing focus on quality assurance programs, and increasing global health initiatives addressing cancer care. Major trends in the forecast period include advancements in image-guided radiotherapy, advancements in particle therapy, development of novel brachytherapy techniques, advancements in cyberKnife technology, and integration of artificial intelligence in treatment planning.

The forecast of 6.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of proton therapy gantry components sourced from France and Italy, thereby delaying advanced cancer treatments and elevating radiation oncology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cancer is anticipated to drive the expansion of the radiotherapy market. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body, affecting various tissues and organs and leading to a wide range of symptoms. The increasing incidence of cancer is linked to factors such as an aging population, lifestyle changes including poor diet and physical inactivity, high tobacco and alcohol consumption, environmental pollution, and advancements in diagnostic tools that enable earlier detection. Radiotherapy plays a vital role in cancer treatment by precisely targeting and destroying cancerous cells, reducing tumor size, and improving patient outcomes. For example, in August 2024, Macmillan Cancer Support, a UK-based charitable organization supporting cancer patients, reported that more than 3 million people in the UK were living with cancer, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising prevalence of cancer is fueling the growth of the radiotherapy market.

Leading companies in the radiotherapy market are prioritizing the development of innovative technologies, such as image-guided radiotherapy (IGRT), to enhance treatment precision, improve patient outcomes, and minimize damage to surrounding healthy tissues. IGRT utilizes advanced imaging tools to ensure accurate tumor targeting during radiation therapy, allowing real-time tracking and adjustments to the tumor's position for increased precision. For instance, in May 2022, Elekta AB, a Sweden-based medical technology company, introduced the Elekta Esprit, a next-generation radiosurgery system that enhances the capabilities of stereotactic radiosurgery. This system integrates multiple innovations into a single platform, offering superior visualization and remote accessibility for treatment teams. It supports flexible workflow options, including single-session, fractionated, adaptive, or staged protocols, optimizing ease of use and efficiency in clinical settings. With an accuracy of less than 0.3 mm, the system is designed to treat even the most challenging targets while preserving surrounding healthy tissues.

In February 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired RayzeBio Inc. for an undisclosed amount. This acquisition strengthens its oncology pipeline with advanced radiopharmaceutical therapeutics, including RYZ101, which targets SSTR2 in GEP-NETs and ES-SCLC. With ongoing clinical trials and a state-of-the-art manufacturing facility, this strategic move enables Bristol Myers Squibb to accelerate innovation, expand treatment options, and drive growth in the oncology sector. RayzeBio Inc. is a US-based company specializing in the development of innovative radiopharmaceuticals for cancer treatment.

Major players in the radiotherapy market are Hitachi Ltd., Koninklijke Philips N.V., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.

North America was the largest region in the radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotherapy market includes revenues earned by entities by providing services such as brachytherapy, palliative radiotherapy, proton therapy, and intraoperative radiotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiotherapy market consists of sales of patient positioning systems, surface-guided radiation therapy systems (SGRT), CT and MRI simulation systems, and linear accelerators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Therapy Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy; Systemic Radiation Therapy
  • 2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Gynecological Cancer; Cervical Cancer; Penile Cancer; Other Applications
  • 3) By End-User: Hospitals And Diagnostic Laboratories; Cancer Treatment And Research Centers; Academic Research Organizations; Ambulatory Surgery Centers; Other End-Users
  • Subsegments:
  • 1) By External Beam Radiation Therapy: Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Body Radiation Therapy (SBRT); 3D Conformal Radiation Therapy (3D-CRT); Proton Beam Therapy; Image-Guided Radiation Therapy (IGRT); Volumetric Modulated Arc Therapy (VMAT)
  • 2) By Internal Beam Radiation Therapy: Brachytherapy (High-Dose Rate); Brachytherapy (Low-Dose Rate); Intraoperative Radiation Therapy (IORT); Permanent Seed Implants
  • 3) By Systemic Radiation Therapy: Radioisotope Therapy; Targeted Radionuclide Therapy; Radioimmunotherapy; Peptide Receptor Radionuclide Therapy (PRRT)
  • Companies Mentioned: Hitachi Ltd.; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.; Elekta AB; Accuray Incorporated; Ion Beam Applications S.A; Canon Medical Systems Corporation; RefleXion Medical Inc.; Mevion Medical Systems Inc.; Nordion Inc.; Theragenics Corporation; RaySearch Laboratories AB; MIM Software Inc.; Vision RT Ltd.; Sun Nuclear Corporation; Provision Healthcare LLC; Panacea Medical Technologies Pvt. Ltd.; Optivus Proton Therapy Inc.; Perspective Therapeutics Inc.; GT Medical Technologies Inc.; ProTom International Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotherapy Market Characteristics

3. Radiotherapy Market Trends And Strategies

4. Radiotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Radiotherapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Radiotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Radiotherapy Market Growth Rate Analysis
  • 5.4. Global Radiotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Radiotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Radiotherapy Total Addressable Market (TAM)

6. Radiotherapy Market Segmentation

  • 6.1. Global Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
  • Systemic Radiation Therapy
  • 6.2. Global Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head And Neck Cancer
  • Colorectal Cancer
  • Gynecological Cancer
  • Cervical Cancer
  • Penile Cancer
  • Other Applications
  • 6.3. Global Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Cancer Treatment And Research Centers
  • Academic Research Organizations
  • Ambulatory Surgery Centers
  • Other End-Users
  • 6.4. Global Radiotherapy Market, Sub-Segmentation Of External Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Stereotactic Body Radiation Therapy (SBRT)
  • 3D Conformal Radiation Therapy (3D-CRT)
  • Proton Beam Therapy
  • Image-Guided Radiation Therapy (IGRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • 6.5. Global Radiotherapy Market, Sub-Segmentation Of Internal Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brachytherapy (High-Dose Rate)
  • Brachytherapy (Low-Dose Rate)
  • Intraoperative Radiation Therapy (IORT)
  • Permanent Seed Implants
  • 6.6. Global Radiotherapy Market, Sub-Segmentation Of Systemic Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radioisotope Therapy
  • Targeted Radionuclide Therapy
  • Radioimmunotherapy
  • Peptide Receptor Radionuclide Therapy (PRRT)

7. Radiotherapy Market Regional And Country Analysis

  • 7.1. Global Radiotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Radiotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotherapy Market

  • 8.1. Asia-Pacific Radiotherapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotherapy Market

  • 9.1. China Radiotherapy Market Overview
  • 9.2. China Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotherapy Market

  • 10.1. India Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotherapy Market

  • 11.1. Japan Radiotherapy Market Overview
  • 11.2. Japan Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotherapy Market

  • 12.1. Australia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotherapy Market

  • 13.1. Indonesia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotherapy Market

  • 14.1. South Korea Radiotherapy Market Overview
  • 14.2. South Korea Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotherapy Market

  • 15.1. Western Europe Radiotherapy Market Overview
  • 15.2. Western Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotherapy Market

  • 16.1. UK Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotherapy Market

  • 17.1. Germany Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotherapy Market

  • 18.1. France Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotherapy Market

  • 19.1. Italy Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotherapy Market

  • 20.1. Spain Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotherapy Market

  • 21.1. Eastern Europe Radiotherapy Market Overview
  • 21.2. Eastern Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotherapy Market

  • 22.1. Russia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotherapy Market

  • 23.1. North America Radiotherapy Market Overview
  • 23.2. North America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotherapy Market

  • 24.1. USA Radiotherapy Market Overview
  • 24.2. USA Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotherapy Market

  • 25.1. Canada Radiotherapy Market Overview
  • 25.2. Canada Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotherapy Market

  • 26.1. South America Radiotherapy Market Overview
  • 26.2. South America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotherapy Market

  • 27.1. Brazil Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotherapy Market

  • 28.1. Middle East Radiotherapy Market Overview
  • 28.2. Middle East Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotherapy Market

  • 29.1. Africa Radiotherapy Market Overview
  • 29.2. Africa Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotherapy Market Competitive Landscape And Company Profiles

  • 30.1. Radiotherapy Market Competitive Landscape
  • 30.2. Radiotherapy Market Company Profiles
    • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Radiotherapy Market Other Major And Innovative Companies

  • 31.1. Elekta AB
  • 31.2. Accuray Incorporated
  • 31.3. Ion Beam Applications S.A
  • 31.4. Canon Medical Systems Corporation
  • 31.5. RefleXion Medical Inc.
  • 31.6. Mevion Medical Systems Inc.
  • 31.7. Nordion Inc.
  • 31.8. Theragenics Corporation
  • 31.9. RaySearch Laboratories AB
  • 31.10. MIM Software Inc.
  • 31.11. Vision RT Ltd.
  • 31.12. Sun Nuclear Corporation
  • 31.13. Provision Healthcare LLC
  • 31.14. Panacea Medical Technologies Pvt. Ltd.
  • 31.15. Optivus Proton Therapy Inc.

32. Global Radiotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotherapy Market

34. Recent Developments In The Radiotherapy Market

35. Radiotherapy Market High Potential Countries, Segments and Strategies

  • 35.1 Radiotherapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Radiotherapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Radiotherapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer